Atractylodin Ameliorates Colitis via PPARα Agonism.

Atractylodin Ameliorates Colitis via PPARα Agonism.
复制标题

DOI:
10.3390/ijms24010802
复制
发表时间:
2023-01-02
影响因子:
5.6
通讯作者:
Im, Eunok
Im, Eunok
中科院分区:
生物学2区
文献类型:
--
作者:
Heo, Gwangbeom;Kim, Yuju;Kim, Eun-La;Park, Soyeong;Rhee, Sang Hoon;Jung, Jee H. H.;Im, Eunok

文献摘要

参考文献

被引文献

相似文献

苍术素是苍术根茎中的一种主要化合物,苍术是一种用于治疗消化不良、恶心和腹泻等胃肠道疾病的东方草药。近年来的研究表明,苍术素对多种炎性疾病均有抗炎作用。本文研究苍术素的抗结肠炎作用及其分子靶点。我们通过结肠上皮细胞增殖实验确定了白术素(50 μM)的非细胞毒性浓度。我们发现白术素预处理能显著抑制HCT116细胞中肿瘤坏死因子-α-诱导的活化B核因子-κ-轻链增强子磷酸化。通过对接模拟分析、荧光素酶实验和体外结合实验,我们发现白术素对过氧化物酶体增殖激活受体α (PPARα)具有亲和力。每日给药白术素(40 mg/kg)可提高右旋糖酐硫酸钠诱导结肠炎小鼠模型小鼠的存活率。因此,苍术素可以通过诱导ppar α依赖途径成为治疗结肠炎的良好策略。
Atractylodin is a major compound in the rhizome of Atractylodes lancea, an oriental herbal medicine used for the treatment of gastrointestinal diseases, including dyspepsia, nausea, and diarrhea. Recent studies have shown that atractylodin exerts anti-inflammatory effects in various inflammatory diseases. Herein, we investigated the anti-colitis effects of atractylodin and its molecular targets. We determined the non-cytotoxic concentration of atractylodin (50 μM) using a cell proliferation assay in colonic epithelial cells. We found that pretreatment with atractylodin significantly inhibits tumor necrosis factor-α-induced phosphorylation of nuclear factor-κ-light-chain-enhancer of activated B in HCT116 cells. Through docking simulation analysis, luciferase assays, and in vitro binding assays, we found that atractylodin has an affinity for peroxisome proliferator-activated receptor alpha (PPARα). Daily administration of atractylodin (40 mg/kg) increased the survival rate of mice in a dextran sodium sulfate-induced colitis mouse model. Thus, atractylodin can be a good strategy for colitis therapy through inducing PPARα-dependent pathways.
DOI: 10.18632/oncotarget.17695
发表时间: 2017-07-11
期刊: Oncotarget
影响因子: --
作者:
Kim SM;Lee B;An HJ;Kim DH;Park KC;Noh SG;Chung KW;Lee EK;Kim KM;Kim DH;Kim SJ;Chun P;Lee HJ;Moon HR;Chung HY
通讯作者: Chung HY
DOI: 10.1038/sigtrans.2017.23
发表时间: 2017
影响因子: 39.3
作者:
Liu T;Zhang L;Joo D;Sun SC
通讯作者: Sun SC
炎症性肠病:发病机制
DOI: 10.3748/wjg.v20.i1.91
发表时间: 2014-01-07
影响因子: 4.3
作者:
Zhang, Yi-Zhen;Li, Yong-Yu
通讯作者: Li, Yong-Yu
DOI: 10.1016/j.jphs.2017.11.010
发表时间: 2018-04-01
影响因子: 3.5
作者:
Tang, Fayin;Fan, Kefeng;Bian, Chuanzhou
通讯作者: Bian, Chuanzhou
DOI: 10.1016/j.intimp.2019.04.005
发表时间: 2019-07-01
影响因子: 5.6
作者:
Lyu, Zheng;Ji, Xufeng;An, Beiying
通讯作者: An, Beiying